NCT00559247 - A Single Ascending Dose Study of BMS-650032 in HCV Infected Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 31, 2008

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions

Chronic Hepatitis C

Interventions

DRUG

BMS-650032 or Placebo

Oral, Once daily, Single Dose

Trial Locations (5)

Parexel International Corporation, Baltimore

Orlando Clinical Research Center, Orlando

Mayo Clinic, Rochester

Alamo Medical Research, San Antonio

West Coast Clinical Trials, Llc, Cypress